1-7 of 7
Keenan T. Hartert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cooperative Networks between MYC and XPO1 Associated with Decreased T-Cell Presence and a Depleted Tumor Microenvironment May be Addressed By the Synergistic Combination of AZD4573 and Selinexor

Kennedee Weber, Aidan Forberg, Jordan Unrau, Alison Rutz, Shelby Lund, Jackson Hauge, Ainslee Hemmen, Keenan T Hartert
Journal: Blood
Blood (2023) 142 (Supplement 1): 2988.
https://doi.org/10.1182/blood-2023-180094
Published: 2023
Journal Articles

EFS24 Failure, BRD4 Expression, and TP53 Are Linked to Reduced CDKN1A Expression in DLBCL and May be Targeted By Single-Agent Protac ARV-825 or in Synergistic Combination with the CDK4/6 Inhibitor Abemaciclib

Alison Rutz, Kennedee Weber, Shelby Lund, Jinda Guidinger, Aidan Forberg, Keenan T. Hartert
Journal: Blood
Blood (2022) 140 (Supplement 1): 3525–3526.
https://doi.org/10.1182/blood-2022-170074
Published: 2022
Journal Articles

The DLBCL Axis of Low TNFRSF10B Expression, TP53 Loss, and a Cold Immune Microenvironment May be Addressed By the Synergistic Combination of Eprenetapopt and Idasnutlin

Alison Rutz, Shelby Lund, Jinda Guidinger, Kennedee Weber, Aidan Forberg, Keenan T. Hartert
Journal: Blood
Blood (2022) 140 (Supplement 1): 6401–6402.
https://doi.org/10.1182/blood-2022-164434
Published: 2022
Journal Articles

TP53 Alterations Enrich in Ezb/C3-like Subclassified Relapsed or Refractory DLBCL and Are Susceptible to BRD4 Protac Inhibition

Shelby Lund, Valentine Ngisa, Zoe Rivard, Jinda Guidinger, Kennedee Weber, Keenan T. Hartert
Journal: Blood
Blood (2021) 138 (Supplement 1): 3503.
https://doi.org/10.1182/blood-2021-144621
Published: 2021
Journal Articles

Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome

Melissa A. Hopper, Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Joseph P. Novak, Michelle K. Manske, MaKayla R. Serres, Vivekananda Sarangi, Melissa C. Larson, Matthew J. Maurer, Jonas Paludo, Ellen D. McPhail, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Stephen M. Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak
Journal: Blood
Blood (2021) 138 (Supplement 1): 808.
https://doi.org/10.1182/blood-2021-147363
Published: 2021
Journal Articles

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Keenan T. Hartert, PhD, Kerstin Wenzl, PhD, Jordan Krull, Michelle Manske, MS, BS, Vivekananda Sarangi, Melissa C Larson, Theodora Anagnostou, MD, Ellen D. McPhail, MD, Brian K. Link, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Dragan Jevremovic, MD PhD, Anne J Novak, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2764.
https://doi.org/10.1182/blood-2019-128803
Published: 2019
Journal Articles

Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways

Keenan T. Hartert, PhD, Kerstin Wenzl, PhD, Jordan Krull, Michelle Manske, MS, BS, Vivekananda Sarangi, Yan Asmann, PhD, Melissa C Larson, MS, Matthew J Maurer, MS, Susan L. Slager, PhD, William R. Macon, MD, Rebecca L. King, MD, Andrew L. Feldman, MD, Anita K Gandhi, Brian K. Link, MD, Thomas M. Habermann, MD, Zhi-Zhang Yang, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Thomas E. Witzig, MD, Grzegorz Nowakowski, MD, Anne J Novak, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1480.
https://doi.org/10.1182/blood-2019-126860
Published: 2019